These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27582408)

  • 1. Quality and consistency of outcome reporting in clinical trials of immunosuppression in renal transplantation.
    Hussain S; Knight SR
    Clin Transplant; 2016 Nov; 30(11):1440-1448. PubMed ID: 27582408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the reporting of renal function endpoints in immunosuppression trials in renal transplantation: time for consensus?
    Knight SR; Hussain S
    Clin Transplant; 2016 Dec; 30(12):1584-1590. PubMed ID: 27740730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Consistency and Reporting of Quality-of-Life Outcomes in Trials of Immunosuppressive Agents in Kidney Transplantation: A Systematic Review and Meta-analysis.
    Howell M; Wong G; Turner RM; Tan HT; Tong A; Craig JC; Howard K
    Am J Kidney Dis; 2016 May; 67(5):762-74. PubMed ID: 26724168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?
    Fleiner F; Fritsche L; Glander P; Neumayer HH; Budde K
    Transplantation; 2006 Mar; 81(5):655-9. PubMed ID: 16534464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level.
    Rombach I; Gray AM; Jenkinson C; Murray DW; Rivero-Arias O
    BMC Med Res Methodol; 2018 Aug; 18(1):87. PubMed ID: 30153796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projecting long-term graft and patient survival after transplantation.
    Levy AR; Briggs AH; Johnston K; MacLean JR; Yuan Y; L'Italien GJ; Kalsekar A; Schnitzler MA
    Value Health; 2014 Mar; 17(2):254-60. PubMed ID: 24636384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Range and Consistency of Outcomes Reported in Randomized Trials Conducted in Kidney Transplant Recipients: A Systematic Review.
    Sautenet B; Tong A; Chapman JR; Warrens AN; Rosenbloom D; Wong G; Gill J; Budde K; Rostaing L; Marson L; Josephson MA; Reese PP; Pruett TL; Evangelidis N; Craig JC
    Transplantation; 2018 Dec; 102(12):2065-2071. PubMed ID: 29781954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Reporting Nutritional Randomized Controlled Trials in Patients With Cystic Fibrosis.
    Daitch V; Babich T; Singer P; Leibovici L
    J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):265-9. PubMed ID: 26881412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistency and completeness of reported outcomes in randomized trials of primary immunosuppression in kidney transplantation.
    Masson P; Duthie FA; Ruster LP; Kelly PJ; Merrifield A; Craig JC; Webster AC
    Am J Transplant; 2013 Nov; 13(11):2892-901. PubMed ID: 24102933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials.
    Le Cleach L; Chassany O; Levy A; Wolkenstein P; Chosidow O
    Dermatology; 2008; 216(1):46-55. PubMed ID: 18032899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of randomized controlled trial quality in pediatric kidney transplantation.
    Brooks RJ; Higgins GY; Webster AC
    Pediatr Nephrol; 2010 Dec; 25(12):2383-92. PubMed ID: 20694479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive treatment options in renal transplantation.
    Ciancio G; Burke GW; Jorge D; Rosen A; Miller J
    Minerva Urol Nefrol; 2005 Sep; 57(3):141-9. PubMed ID: 15986013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: a meta-analysis of randomized controlled trials.
    Tian JH; Wang X; Yang KH; Liu AP; Luo XF; Zhang J
    Transplant Proc; 2009 Nov; 41(9):3671-6. PubMed ID: 19917365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus Versus Cyclosporine as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation.
    Liu JY; You RX; Guo M; Zeng L; Zhou P; Zhu L; Xu G; Li J; Liu D
    Am J Ther; 2016; 23(3):e810-24. PubMed ID: 25299636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completeness of reporting of adverse events in trials of maintenance immunosuppression in kidney transplantation: a systematic review.
    Howell M; Yeo R; Tong A; Craig JC; Howard K; Wong G
    Nephrol Dial Transplant; 2017 Sep; 32(9):1586-1594. PubMed ID: 29059401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus Versus Tacrolimus as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation.
    Liu JY; Song M; Guo M; Huang F; Ma BJ; Zhu L; Xu G; Li J; You RX
    Am J Ther; 2016; 23(6):e1720-e1728. PubMed ID: 25569597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability.
    Muduma G; Odeyemi I; Pollock RF
    J Med Econ; 2014 Jul; 17(7):520-6. PubMed ID: 24754700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial registries are of minimal use for identifying selective outcome and analysis reporting.
    Norris SL; Holmer HK; Fu R; Ogden LA; Viswanathan MS; Abou-Setta AM
    Res Synth Methods; 2014 Sep; 5(3):273-84. PubMed ID: 26052852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials, immunosuppression and renal transplantation: new trends in design and analysis.
    Landais P; Daures JP
    Pediatr Nephrol; 2002 Aug; 17(8):573-84. PubMed ID: 12185461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.